Elan "add"
newratings.com - USA
... rather than the previous estimate of profits of $7.4 million due to the pullback of revenue estimates for Tysabri and higher cost estimates. ...
See all stories on this topic

McGrigor call for MS drug to be put on NHS
Shetland Times - Lerwick,Scotland,UK
However, the SMC's decision not to recommend Tysabri for use in the NHS has come as a bitter blow to patients with the most aggressive form of the disease, ...
See all stories on this topic

Needed From the FDA: Not Perfection, Just Consistency
TCS Daily - Washington,DC,USA
In recent decisions on the post-approval risk management of two drugs, Tysabri and Rituxan, FDA regulators have failed to be internally consistent - and ...
See all stories on this topic

"Multiple Sclerosis: The Latest Findings"
Garden City News - Garden City,NY,USA
Sharon-Friedman Urevich, RN, NP, Coordinator of Winthrop's MS Program; Eileen Boylan, RN, and Denise Cheng, RN, will the practical aspect of Tysabri(r), ...
See all stories on this topic

Multiple sclerosis drug brings lethal risks, but great promise for ...
Monterey County Herald - Monterey,CA,USA
After a horrible year of MS relapses in 2006, she reckons that the same drug, Tysabri, will reduce the odds of another setback from which she might not ...
See all stories on this topic